浏览全部资源
扫码关注微信
- Journal Information
- Archive
- Submission
- For Reviewers
- Statement and Policies
Research progress on the intervention of traditional Chinese medicine monomer and formula in the mTOR signaling pathway for the treatment of osteoporosis
- ZHONGGUO YAOFANG Vol. 34, Issue 23, Pages: 2934-2938(2023)
- 作者机构：
1.河南中医药大学第一附属医院内分泌科，郑州 450003
2.河南中医药大学第一临床医学院，郑州 450003
3.郑州市中医院糖尿病科，郑州 450006
4.郑州人民医院中医科，郑州 450053
- 作者简介：
- 基金信息：
DOI：10.6039/j.issn.1001-0408.2023.23.21
CLC： R965;R285.5Published：15 December 2023，
Received：21 June 2023，
Revised：14 October 2023，
扫 描 看 全 文
陈言,单留峰,车文生等.中药单体及复方干预mTOR信号通路治疗骨质疏松症的研究进展 Δ[J].中国药房,2023,34(23):2934-2938.
CHEN Yan,SHAN Liufeng,CHE Wensheng,et al.Research progress on the intervention of traditional Chinese medicine monomer and formula in the mTOR signaling pathway for the treatment of osteoporosis[J].ZHONGGUO YAOFANG,2023,34(23):2934-2938.
陈言,单留峰,车文生等.中药单体及复方干预mTOR信号通路治疗骨质疏松症的研究进展 Δ[J].中国药房,2023,34(23):2934-2938. DOI： 10.6039/j.issn.1001-0408.2023.23.21.
CHEN Yan,SHAN Liufeng,CHE Wensheng,et al.Research progress on the intervention of traditional Chinese medicine monomer and formula in the mTOR signaling pathway for the treatment of osteoporosis[J].ZHONGGUO YAOFANG,2023,34(23):2934-2938. DOI： 10.6039/j.issn.1001-0408.2023.23.21.
摘要
骨质疏松症是导致骨骼弱化、易于骨折的重要原因，西医抗骨质疏松药物并不能逆转其进程，只能减少骨密度的流失，且长期应用伴随一定不良反应，而中医药注重辨证施治和整体观念，可弥补西医治疗的短板。哺乳动物雷帕霉素靶蛋白（mTOR）信号通路参与骨细胞的生长、增殖和分化过程，与骨质疏松症的发生和发展密切相关。近年来，多种中药单体（如黄酮类、多糖类、生物碱类等）及中药复方（如补肾活血汤、六味地黄丸、二至丸等）被证明能够通过调节mTOR信号通路促进骨形成、抑制骨吸收、增强骨细胞自噬，进而延缓骨质疏松症的进展。基于此，本文总结了干预mTOR信号通路治疗骨质疏松症的中药单体及复方，以期为骨质疏松症的中医治疗提供用药思路。
Abstract
Osteoporosis is an important cause of bone weakness and susceptibility to fractures. Anti-osteoporosis drugs of Western medicine cannot reverse its progression， and can only reduce the loss of bone density； long-term use of them is accompanied by certain adverse reactions. Traditional Chinese medicine focuses on syndrome differentiation and holistic approach， which can make up for the shortcomings of Western medicine’s treatment. The mammalian target of rapamycin （mTOR） signaling pathway is involved in the growth， proliferation， and differentiation of bone cells， and is closely related to the occurrence and development of osteoporosis. In recent years， various traditional Chinese medicine monomers （such as flavonoids， polysaccharides， alkaloids， etc.） and traditional Chinese medicine formulas （such as Bushen huoxue decoction， Liuwei dihuang pills， Erzhi pills， etc.） have been proven to promote bone formation， inhibit bone resorption， enhance bone cell autophagy， and delay the progression of osteoporosis by regulating the mTOR signaling pathway. Therefore， the article summarizes the traditional Chinese medicine monomer and formula that intervene in the mTOR signaling pathway for the treatment of osteoporosis， in order to provide medication ideas for the traditional Chinese medicine treatment of osteoporosis.
关键词
中药单体复方骨质疏松症mTOR信号通路
Keywords
monomerformulaosteoporosismTOR signaling pathway
references
中国疾病预防控制中心慢性非传染性疾病预防控制中心，中华医学会骨质疏松和骨矿盐疾病分会. 中国骨质疏松症流行病学调查报告：2018[M]. 北京：人民卫生出版社，2021：2-3.
National Center for Chronic and Noncommunicable Disease Control and Prevention of the Chinese Center for Disease Control and Prevention，Osteoporosis and Bone Mineral Salt Diseases Branch of the Chinese Medical Association. Epidemiological investigation report on osteoporosis in China：2018[M]. Beijing：People’s Medical Publishing House，2021：2-3.
中华医学会骨质疏松和骨矿盐疾病分会，章振林. 原发性骨质疏松症诊疗指南：2022[J]. 中国全科医学，2023，26（14）：1671-1691.
Osteoporosis and Bone Mineral Salt Diseases Branch of the Chinese Medical Association，ZHANG Z L. Guidelines for the diagnosis and treatment of primary osteoporosis：2022[J]. Chin Gen Pract，2023，26（14）：1671-1691.
CHENG T，ZHANG Y C，FAN K Y，et al. Genetic evidence supporting a causal association between mTOR-dependent EIF-4E circulating protein level and osteoporosis[J]. Adv Ther，2023，40（11）：4987-4998.
LAPLANTE M，SABATINI D M. mTOR signaling in growth control and disease[J]. Cell，2012，149（2）：274-293.
SAXTON R A，SABATINI D M. mTOR signaling in growth，metabolism，and disease[J]. Cell，2017，169（2）：361-371.
HIRAIWA M，OZAKI K，YAMADA T，et al. mTORC1 activation in osteoclasts prevents bone loss in a mouse model of osteoporosis[J]. Front Pharmacol，2019，10：684.
SUHARA T，BABA Y，SHIMADA B K，et al. The mTOR signaling pathway in myocardial dysfunction in type 2 diabetes mellitus[J]. Curr Diab Rep，2017，17（6）：38.
WANG S，DENG Z T，MA Y C，et al. The role of autophagy and mitophagy in bone metabolic disorders[J]. Int J Biol Sci，2020，16（14）：2675-2691.
CHEN J Q，LONG F X. mTOR signaling in skeletal deve- lopment and disease[J]. Bone Res，2018，6：1.
KIM J H，KIM N. Signaling pathways in osteoclast diffe- rentiation[J]. Chonnam Med J，2016，52（1）：12-17.
SHEN G Y，REN H，QIU T，et al. Mammalian target of rapamycin as a therapeutic target in osteoporosis[J]. J Cell Physiol，2018，233（5）：3929-3944.
WANG J R，XU C Y，ZHANG J，et al. RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling[J]. Mol Med，2023，29（1）：49.
WU H G，WU Z X，LI P，et al. Bone size and quality regulation：concerted actions of mTOR in mesenchymal stromal cells and osteoclasts[J]. Stem Cell Reports，2017，8（6）：1600-1616.
王云飞，王会方，史栋梁，等. 金丝桃苷激活Sirt1/AMPK自噬通路改善糖尿病骨质疏松大鼠骨代谢和骨结构的机制研究[J]. 中国病理生理杂志，2023，39（3）：434-444.
WANG Y F，WANG H F，SHI D L，et al. Hyperoside improves bone metabolism and bone structure in diabetic osteoporosis rats via Sirt1/AMPK signaling pathway[J]. Chin J Pathophysiol，2023，39（3）：434-444.
宋世雷. 基于miR-17-5p/MAPK/mTOR信号探讨淫羊藿苷促进成骨细胞自噬机制研究[D]. 南宁：广西中医药大学，2021.
SONG S L. Study on the mechanism of icariin promoting osteoblast autophagy based on miR-17-5p/MAPK/mTOR signal[D]. Nanning：Guangxi University of Chinese Medicine，2021.
赵晶. 杜仲叶提取物山柰酚对卵巢去势大鼠骨生成的影响及其与mTOR信号通路的关系研究[D]. 南昌：南昌大学，2019.
ZHAO J. Effect of kaempferol in Eucommia ulmoides on osteogenesis in ovariectomized rats and its relationship with mTOR signaling pathway[D]. Nanchang：Nanchang University，2019.
GE X T，ZHOU G. Protective effects of naringin on glucocorticoid-induced osteoporosis through regulating the PI3K/Akt/mTOR signaling pathway[J]. Am J Transl Res，2021，13（6）：6330-6341.
SUN J，PAN Y L，LI X F，et al. Quercetin attenuates osteoporosis in orchiectomy mice by regulating glucose and lipid metabolism via the GPRC6A/AMPK/mTOR signa- ling pathway[J]. Front Endocrinol，2022，13：849544.
MU P Y，HU Y M，MA X，et al. Total flavonoids of Rhizoma Drynariae combined with calcium attenuate osteoporosis by reducing reactive oxygen species generation[J]. Exp Ther Med，2021，21（6）：618.
马伟凤，王亮，马彦巧，等. 人参皂苷Rg3通过调节AMPK/mTOR信号通路提高骨质疏松老年大鼠骨密度及骨代谢[J]. 广州中医药大学学报，2023，40（1）：163-169.
MA W F，WANG L，MA Y Q，et al. Ginsenoside Rg3 enhances bone mineral density and bone metabolism in osteoporotic aged rats through regulation of AMPK/mTOR signaling pathway[J]. J Guangzhou Univ Tradit Chin Med，2023，40（1）：163-169.
胡广，关智宇，张开伟. 三七总皂苷干预去势骨质疏松性骨折模型大鼠的作用机制[J]. 中国组织工程研究，2021，25（2）：172-177.
HU G，GUAN Z Y，ZHANG K W. Mechanism underlying the interventional effect of Panax Notoginsenosides on ovariectomized osteoporotic fracture rats[J]. Chin J Tissue Eng Res，2021，25（2）：172-177.
孙文星，黄万新，刘传慧，等. 黄芪多糖通过PI3K/Akt/mTOR促进激素性骨质疏松症大鼠成骨细胞增殖[J]. 中国骨质疏松杂志，2023，29（1）：35-40.
SUN W X，HUANG W X，LIU C H，et al. Astragalus polysaccharide promotes the proliferation of osteoblasts in hormonal osteoporosis rats through PI3K/Akt/mTOR signaling pathway[J]. Chin J Osteoporos，2023，29（1）：35-40.
ZHAO B K，PENG Q，POON E H L，et al. Leonurine promotes the osteoblast differentiation of rat BMSCs by activation of autophagy via the PI3K/AKT/mTOR pathway[J]. Front Bioeng Biotechnol，2021，9：615191.
陈露华，唐宏宇. 补骨脂素对绝经后大鼠骨质疏松及PI3K/Akt/mTOR信号通路的影响[J]. 中国药房，2021，32（6）：697-701.
CHEN L H，TANG H Y. Effect of psoralen on osteoporosis in postmenopausal rats and PI3K/AKT/mTOR signa- ling pathway[J]. China Pharm，2021，32（6）：697-701.
杨烙坚，周小海，刘力菠，等. 补肾活血汤对去卵巢骨质疏松小鼠的干预作用研究：基于PI3K/AKT/mTOR信号通路[J]. 亚太传统医药，2023，19（5）：36-41.
YANG L J，ZHOU X H，LIU L B，et al. Mechanism of Bushen huoxue decoction in the treatment of rats based on PI3K/AKT/mTOR signaling pathway[J]. Asia Pac Tradit Med，2023，19（5）：36-41.
谢丽华，郭澜，陈赛楠，等. 基于ERK/mTOR信号通路探讨六味地黄丸对氧化应激状态下成骨细胞自噬的影响[J]. 中国骨质疏松杂志，2023，29（1）：1-5.
XIE L H，GUO L，CHEN S N，et al. Liuwei dihuang pills induce osteoblast autophagy under oxidative stress via ERK/mTOR signaling pathway[J]. Chin J Osteoporos，2023，29（1）：1-5.
陈知斌，张文达，胡美思，等. 左、右归丸调控AMPK/mTOR信号通路促进绝经后骨质疏松症大鼠骨形成的研究[J]. 中华中医药杂志，2021，36（6）：3584-3588.
CHEN Z B，ZHANG W D，HU M S，et al. Study on mechanism of bone formation of PMOP rats by Zuogui pills and Yougui pills based on AMPK/mTOR signaling pathway[J]. China J Tradit Chin Med Pharm，2021，36（6）：3584-3588.
刘孟初. 基于PI3K/AKT/mTOR通路探讨生骨再造丸对SANFH兔BMSCs成骨分化影响的实验研究[D]. 兰州：甘肃中医药大学，2022.
LIU M C. Shenggu zaizaowan on osteogenic differentiation of SANFH rabbit BMSCs based on PI3K/AKT/mTOR pathway[D]. Lanzhou：Gansu University of Chinese Medicine，2022.
米健国，乔荣勤，刘少津. 补肾健脾活血方干预骨质疏松模型大鼠骨代谢、氧化应激及自噬的变化[J]. 中国组织工程研究，2022，26（26）：4147-4152.
MI J G，QIAO R Q，LIU S J. Bushen jianpi huoxue recipe improves bone metabolism，oxidative stress，and autophagy in osteoporotic rats[J]. Chin J Tissue Eng Res，2022，26（26）：4147-4152.
熊梦欣. 基于丁酸介导的AMPK/mTOR/ULK1信号通路探讨补肾化痰方防治绝经后骨质疏松症的机制研究[D]. 武汉：湖北中医药大学，2022.
XIONG M X. The mechanism study of Bushen huatan decoction in preventing and treating postmenopausal osteoporosis based on butyric acid-mediated AMPK/mTOR/ULK1 signaling pathway[D]. Wuhan：Hubei University of Chinese Medicine，2022.
强胜林，刘涛，贾永龙，等. 补肾固本方对大鼠骨质疏松模型中PI3K/Akt/mTOR信号通路表达的调控研究[J]. 中国骨质疏松杂志，2020，26（7）：983-987.
QIANG S L，LIU T，JIA Y L，et al. Regulation of the expression of PI3K/Akt/mTOR signaling pathway by nou- rishing kidney and consolidating fundamental recipe in rat osteoporosis model[J]. Chin J Osteoporos，2020，26（7）：983-987.
田涛，傅强，朱健奎，等. 二至丸治疗斑马鱼骨质疏松模型效益观察及破骨细胞自噬机制[J]. 南京中医药大学学报，2020，36（3）：352-357.
TIAN T，FU Q，ZHU J K，et al. Observation on the effect of Erzhiwan on zebrafish osteoporosis model and study on autophagy mechanism of osteoclast[J]. J Nanjing Univ Tradit Chin Med，2020，36（3）：352-357.
于岩松. 基于mTOR信号通路探讨补正续骨丸对PMOP及骨质疏松性骨折的作用机理[D]. 沈阳：辽宁中医药大学，2018.
YU Y S. Based on mTOR signal pathway discusses the action mechanism of Buzheng xugu pill on PMOP and osteoporotic fracture[D].Shenyang：Liaoning University of Traditional Chinese Medicine，2018.
杨依然. CKIP-1介导mTOR通路对绝经后骨质疏松症致病机理及强骨饮对其干预的研究[D]. 杭州：浙江中医药大学，2021.
YANG Y R. The interaction between CKIP-1 and mTOR in postmenopausal osteoporosis and the pharmacological study of Qiangguyin[D]. Hangzhou：Zhejiang Chinese Medical University，2021.
0
Views
1
下载量
0
CSCD
- L-PDFDownload
- WORDDownload
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
- Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号
公网安备50010302001817 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.